GLP-1 users face 6 rebound risks after stopping the weight-loss drugs
Top Story
Archived
•
November 12, 2026
•
While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.
Source: New York Post | https://nypost.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


